Lucid Diagnostics Inc.Lucid Diagnostics Inc.Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

No trades
See on Supercharts
Market capitalization
‪38.55 M‬USD
‪−52.67 M‬USD
‪2.43 M‬USD
‪14.29 M‬
Beta (1Y)

About Lucid Diagnostics Inc.

Lishan Aklog
New York
Employees (FY)
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LUCD is 0.7965 USD — it has decreased by 0.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lucid Diagnostics Inc. stocks are traded under the ticker LUCD.
Lucid Diagnostics Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
LUCD stock is 5.88% volatile and has beta coefficient of 0.19. Check out the list of the most volatile stocks — is Lucid Diagnostics Inc. there?
One year price forecast for Lucid Diagnostics Inc. has a max estimate of 8.0000 USD and a min estimate of 2.5000 USD.
LUCD earnings for the last quarter are −0.22 USD per share, whereas the estimation was −0.24 USD resulting in a 7.37% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Lucid Diagnostics Inc. earnings.
Lucid Diagnostics Inc. revenue for the last quarter amounts to ‪783.00 K‬ USD despite the estimated figure of ‪799.67 K‬ USD. In the next quarter revenue is expected to reach ‪1.04 M‬ USD.
Yes, you can track Lucid Diagnostics Inc. financials in yearly and quarterly reports right on TradingView.
LUCD stock has fallen by 9.49% compared to the previous week, the month change is a 25.56% fall, over the last year Lucid Diagnostics Inc. has showed a 49.59% decrease.
LUCD net income for the last quarter is ‪−10.83 M‬ USD, while the quarter before that showed ‪−14.21 M‬ USD of net income which accounts for 23.78% change. Track more Lucid Diagnostics Inc. financial stats to get the full picture.
Today Lucid Diagnostics Inc. has the market capitalization of ‪38.55 M‬, it has increased by 1.81% over the last week.
No, LUCD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LUCD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lucid Diagnostics Inc. stock right from TradingView charts — choose your broker and connect to your account.
LUCD reached its all-time high on Oct 14, 2021 with the price of 13.5200 USD, and its all-time low was 0.7811 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 70.00 employees. See our rating of the largest employees — is Lucid Diagnostics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lucid Diagnostics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lucid Diagnostics Inc. stock shows the sell signal. See more of Lucid Diagnostics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Lucid Diagnostics Inc. future price: according to them, LUCD price has a max estimate of 8.00 USD and a min estimate of 2.50 USD. Read a more detailed Lucid Diagnostics Inc. forecast: see what analysts think of Lucid Diagnostics Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lucid Diagnostics Inc. EBITDA is ‪−45.98 M‬ USD, and current EBITDA margin is ‪−1.89 K‬%. See more stats in Lucid Diagnostics Inc. financial statements.